Sean & Greg — Biology and ML for Drug Discovery
Gradient Dissent: Conversations on AI
00:00
How to Grow a Revenue Base in a Market Like That?
The way we structure r revenues is, one, that the farmer partner pays us a to actually develop the drug candidate. And then we get paid on milestone payments as they progress through the clinical tri so you get, you know, milestone payment at phase one, fase two, fase three, ultimately approval and thend and then royalties. So even if a drug doesn't make it to the clinic, you still get paid these these milestone payments, which are 100 % pure margin. But you grow the revenue base just by growing the number of programs every year. Is there an order of magnitude in how manys you're doing? Is it like thousands? It's more ynow on
Transcript
Play full episode
